Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a s... Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine. Mehr anzeigen
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the...
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and Contribution and Share Exchange Agreement...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4584 | -11.7538461538 | 3.9 | 4 | 3.27 | 17930 | 3.67239426 | CS |
| 4 | -0.6584 | -16.0585365854 | 4.1 | 4.5 | 3.27 | 21193 | 3.83386397 | CS |
| 12 | -2.2184 | -39.1943462898 | 5.66 | 6.05 | 3.27 | 14027 | 4.3131566 | CS |
| 26 | -3.3384 | -49.2389380531 | 6.78 | 14.8 | 3.27 | 229580 | 9.40138891 | CS |
| 52 | -2.3164 | -40.2292462661 | 5.758 | 14.8 | 3.27 | 125408 | 9.23400847 | CS |
| 156 | -21.9584 | -86.4503937008 | 25.4 | 31.8 | 3.27 | 163095 | 15.59739004 | CS |
| 260 | -98.1384 | -96.6119314826 | 101.58 | 327 | 3.27 | 3859970 | 132.81456589 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
